MedPath

The effects of green tea-derived components on acute upper respiratory tract inflammation for health care workers; single-blinded randomized parallel-group trial

Not Applicable
Conditions
Acute upper respiratory tract inflammation
Registration Number
JPRN-UMIN000030103
Lead Sponsor
niversity of Shizuoka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Potentially having the allergy to tea-derived components (2) Having severe systemic chronic infectious diseases (3) Being difficulty to participate the study due to having severe hepatic/renal/ cardiac/respiratory/endocrinological/metabolic disorder, neurological and consciousness disorder, diabetes and other illnesses (4) Having severe immune deficiency or autoimmune disease, or taking drugs influencing immune functions (e.g. steroid, immunosuppressive drugs, and so on) (5) Not able to stop health products or supplements that potentially influence immune functions (6) Going to participate any clinical trial other than this study (7) Subjects diagnosed by physicians inappropriate to participate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath